Author:
Roed Henrik,Vindelov Lars L.,Christensen Ib J.,Spang-Thomsen Mogens,Hansen Heine Hoi
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference22 articles.
1. Allen LM, Creaven PJ (1975) Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives. Eur J Cancer 11:697?707
2. Allen LM (1978) Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4?-demethyl epipodophyllotoxin thenylidene-?-D-glucoside ind 4?-demethyl epipodophyllotoxin ethylidene-?-D-glucoside in the L1210 leukemia cell. Cancer Res 38:2549?2554
3. Bork E, Hansen M, Dombernowsky P, Hansen SW, Pedersen AG, Hansen HH, (1986) Teniposide (VM-26), an overlooked highly active agent in small cell lung cancer. Results of a phase II trial. J Clin Oncol 4:524?527
4. Christensen I, Hartmann NR, Keiding N, Larsen JK, Noer H, Vindeløv L (1978) Statistical analysis of DNA distributions from cell populations with partial synchrony. In: Lutz D (ed) Pulsecytophotometry, part 3. European Press Medicon, Ghent, pp 71?78
5. Creaven PJ (1982) The clinical pharmacology of VM-26 and VP-16-213, a brief overview. Cancer Chemother Pharmacol 7: 133?140
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献